Actively Recruiting

Age: 18Years +
All Genders
NCT03720613

Risk of Major Adverse Cardiovascular Events for Naldemedine & Other Medications for Opioid Induced Constipation

Led by BioDelivery Sciences International · Updated on 2025-02-12

34532

Participants Needed

1

Research Sites

617 weeks

Total Duration

On this page

Sponsors

B

BioDelivery Sciences International

Lead Sponsor

H

HealthCore, Inc.

Collaborating Sponsor

AI-Summary

What this Trial Is About

The research objective is to characterize the risk of a major adverse cardiovascular event (MACE) among new users of naldemedine versus new users of lubiprostone and new users of naloxegol as comparator opioid induced constipation (OIC) medications.

CONDITIONS

Official Title

Risk of Major Adverse Cardiovascular Events for Naldemedine & Other Medications for Opioid Induced Constipation

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • At least one dispensing of naldemedine or lubiprostone or naloxegol without prior use in the database of either medication (index date)
  • At least two dispensings of opioids within six months prior to and including the index date, with at least a combined 31 cumulative days supply
  • At least 18 years of age or older on the index date
  • At least six months of continuous health plan coverage that includes medical and pharmacy benefits prior to and including the index date
Not Eligible

You will not qualify if you...

  • Any acute MACE (non-fatal MI or non-fatal stroke) within six months before or on the index date
  • Any cancer treatment or cancer pain diagnosis within six months before or on the index date
  • Prior use of methylnaltrexone, alvimopan or naloxegol within six months before or on the index date

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Research Site

Wilmington, Delaware, United States, 19801

Actively Recruiting

Loading map...

Research Team

T

Todd Kunkel

CONTACT

T

Tom Smith

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here